MDD Flashcards

1
Q

Most common mood disorder

A

Depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Classified as a unipolar mood disorder

A

Major depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Classified as when an emotional state, such as sadness, becomes chronic and uncontrollable.

A

Major depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Have an unclear nature of how they occur due to the difficult availabilty of human brain tissue for neurochemical measurement until patients are post-mortem.

A

Mood disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Range of greater prevalence of women than men with regards to epidemiology of MDD according to age in adolescence - mid 50’s

A

1.7 - 2.7 times

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

In 65-80 y.o. people, what percentage does MDD occur in men and women?

A

Men : 9.6%
Women: 20.4 %

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Other prevalence of MDD

A

Comorbid substance abuse
Suicide attempts
Death occuring frequently

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hereditary epidemiology degree of liability

A

37% hereditary liability wherein 8-18% with MDD have atleast a degree relative with a history of depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Environmental epidemiology percentsage

A

63% of the variance in liability was due to an individual-specific environment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Epigenetic factors of MDD

A
  1. Genome
  2. Environment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

2-3 times increase in lifetime risk of developing MDD among first degree relatives with 37% heritability

A

Genome factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

2 types of environmental factor in the epigenetic mechanism of MDD which are 63%

A

Aversive
Protective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Aversive factors

A

Prenatal factors
Childhood trauma
Stress
Medical illness
Drug abuse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Protective

A

Social support
Coping
Exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MDD equation

A

Genome + environment = MDD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Clinical presentations of mdd

A

Affective symptoms
Cognitive symptoms
Somatic - vegetative symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Pathophysiology of MDD

A

Brain network level
- regional brain volumes
- cognitive control circuit

Molecular level
- neurotransmission
- neuropasticity
- stress hormones
- inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Symptoms reported by MDD patients consistently reflect changes in which transmitters?

A

Brain monoamine neurotransmitters (NTs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Symptoms reported by MDD patients consistently reflect changes in which transmitters?

A

Brain monoamine neurotransmitters (NTs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Decreased levels of these amines are typically present in the brains of depressed patients.

A

5-HT, DA, NE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Hypothesis where decreased levels and functional deficiencies of 5-HT, DA, and NE, are typically present in the brains of depressed patients.

A

Monoamine hypothesis (Biogenic Amine Hypothesis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Primary Hypotheses for the development of MDD

A
  1. Monoamine Hypothesis
  2. Neural Plasticity Hypothesis
  3. Neuroinflammatory hypothesis
  4. Hypothalamic-pituitary-adrenal (HPA) axis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Regulates neuronal plasticity

A

Brain-derived neurotrophic factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Might impact the development of synaptic structures, such as axons and dendrites, and their growth and remodeling.
might enhance the long-term synaptic transmission function of the hippocampus through pre- and post-synaptic pathways

A

Brain-derived neurotrophic factor (BDNF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
pathogenesis of depression is significantly influenced by what?
neuroplasticity and remodeling
26
An inflammation-related disease that worsens as inflammation increases and progresses.
Depression
27
glial cell activation in the brains of depressed patients results in the release of what
pro-inflammatory cytokines
28
examples of pro-inflammatory cytokines
Interleukin-6 (IL-6) Interleukin 1 beta (IL-1B) TNF-alpha
29
pro-inflammatory cytokines can lead to what
neuroinflammation and neuronal death
30
glial cells also produce what substances?
Nitric oxide synthase Cyclooxygenase-2 (COX-2)
31
emerged as a novel target for the treatment of depression
Neuroinflammation
32
HPA dysfunction in Px with depression have high _?
Glucocorticoid levels
33
Primary function of the HPA axis
regulate the stress response
34
hormone released by hypothalamus when we are stressed
corticotropin-releasing hormone (CRH)
35
Signals the pituitary gland to secrete a hormone called adrenocorticotropic hormone into the bloodstream
Corticotropin-releasing hormone
36
Site where the ACTH travels down and prompts the release of a hormone called cortisol from the cortex, or outer layer, of the adrenal glands
Adrenal glands
37
helps mobilize energy like glucose so the body has enough power to cope with prolonged stressor
Cortisol
38
senses high levels of cortisol in the blood
receptors in areas of brain like hypothalamus and hippocampus
39
mechanisms involved when cortisol levels in the blood are high
negative feedback mechanism which shuts off the stress response
40
Neurotransmitters
1. Glutamate 2. GABA 3. Dopamine 4. Adrenaline 5. Serotonin 6. Oxytocin 7. Acetylcholine
41
main excitatory neurotransmitter in the CNS
Glutamate
42
main inhibitory neurotransmitter reduces the activity of the CNS blocks certain signals from the brain
GABA
43
most thrilling neurotransmitter plays a major role in the brain's reward system proved critical to CNS functions such as movement, pleasure, attention, mood, and motivation
Dopamine
44
responsible for body's fight or flight response body's defense mechanisms against stress
Adrenaline (epinephrine)
45
promotes satisfaction after eating and keeps appetite in check
Serotonin
46
love hormone
Oxytocin
47
two main actions of oxytocin in the body
1. contraction of the womb during childbirth 2. Lactation
48
directly affects muscles. triggers an action potential or command in the muscle fiber. makes muscle contract instead of sending signals to a brain cell
Acetylcholine
49
A deficit in the concentration of the brain's NE, Dopamine, and/or serotonin resulting in depression
Neurochemical dysregulation
50
Antidepressant therapies focus on what ?
Increasing monoamine neurotransmitter levels within the synapses
51
Lipid soluble and can penetrate the BBB. Binds and inhibits the catecholamine pump on the storage vesicles in central and peripheral adrenergic neurons
Reserpine
52
Inhibits uptake of norepinephrine, dopamine, and serotonin into presynaptic storage vesicles
Reserpine
53
reserpine in combination with these may have additive orthostatic hypotensive effects when used with beta-blockers due to catecholamine depletion.
Beta-blockers
54
may also interfere with reflex tachycardia, worsening the orthostasis
Beta-blockers
55
cause of secretion of pro-inflammatory cytokines which causes immunosuppression and inflammation
Chronic cortisol release in the body
56
results to neuronal atrophy of the hippocampus resulting in no cell growth consequently causing a reduction of the hippocampal brain-derived neurotrophic factor (BDNF)
Neuroendocrine dysregulation
57
Depressed individual's post-mortem brains have shown a widespread decrease in what neurotransmitter receptor subtype??
serotonin or 5HT-1a receptor subtype
58
where does the 5 HT-1a receptor subtype bind?
Frontal. temporal, and limbic cortex
59
what is found in the frontal cortex of some suicide victims with depression?
NE receptor alterations
60
Alterations in NE systems may be linked to what?
Attention or concentration difficulties as well as sleep and arousal disturbances in depression
61
T/F: depressed individuals have also been found to have abnormalities in cerebral blood flow and glucose metabolism
T
62
Duration of symptoms to be present for diagnosis
2 weeks
63
feelings most commonly seen
sadness and despair irritability and hopelessness
64
symptoms
1. depressed or irritable mood 2. loss of interests and pleasures - includes interpersonal relationships 3. significant weight gain or loss (5%0 in a month 4. sleep disturbances: insomnia/hypersomnia 5. psychomotor agitation or retardation: restlessness or agitation 6. fatigue or loss of energy 7. feelings of worthlessness or exccessive guilt: pessimistic/negative outcomes are perceived 8. poor concentration or indecisiveness 9. resent thoughts of suicide/death
65
Affective symptoms of depression
feeling of sadness loss of interest normally pleasurable activities change in appetite and sleep loss of energy problems with concentration and decision-making
66
cognitive symptoms
difficulty remembering, diff. speaking diff. understanding problems of concentrations loss of motivation
67
somatic-vegetative
digestive issues heart palpitations or arrythmias shortness of breath or trouble breathing NV Change in body temperature
68
main objective of Tx
complete remission of depression with full functional recovery and the development of resilience
69
Examples of psychological therapy
1. cognitive behavioral therapy 2. interpersonal therapy 3. acceptance and commitment therapy 4. mindfulness-based cognitive therapy
70
First line pharmacotherapy
- SSRIs, NaSSAs, NDRIs, SNRIs, NARIs - melatonin agonist serotonin modulator
71
Second line pharmacotherapy
TCAs, MAOIs
72
3 Phases for treatment with MDD
1. Acute Phase 2. Continuation Phase 3. Maintenance Phase
73
First-line treatment antidepressant due to safety in overdose and tolerability
SSRIs
74
An SNRI that potentiates the activity of NE and 5-HT by blocking their reuptake. Reported frequently during TCA therapy.
TCA
75
A generation SNRI that inhibits 5-HT in low doses and inhibits NE at high doses
Venlafaxine
76
a new generation SNRI that is a primary active metabolite of venlafaxine
Desvenlafaxine
77
A new generation SNRI with both 5-HT and NE reuptake inhibition across all doses
Duloxetine
78
A mixed serotonergic medication with dual action on serotonergic neurons, acting as both 5-HT antagonists and 5-HT reuptake inhibitors
Trazodone and Nefazodone
79
blocks b-adrenergic and histaminergic receptors (sedation and dizziness)
Trazodone
80
the long-acting release of this was approved by FDA
Trazodone
81
A mixed 5-HT which was declined due to hepatotoxic effect
Nefazodone
82
Block box labeling requirement from FDA warning describing rare cases of liver failure
Nefazodone
83
A serotonin andd A-adrenergic receptor antagonist that Enhances central noradrenergic and serotonergic activity through antagonism of central presynaptic a-adrenoceptor auto receptors and heteroceptors
Metazapine
84
Antagonizes 5HT receptors as well as Histamine receptors Helps lower anxiety and GI effects
Metazapine
85
Increases the concentration of NE, 5-HT, and DA within the neural synapse through inhibition of the MAO enzymes. Chronic therapy causes changes in receptor sensitivity.
MAOIs
86
Nonselective MAOis
Phenelzine and Tranylcypromine
87
Transdermal patch which allows inhibition of MAO-A and MAO-B in the brain, yet has reduced effects on MAO-A in the gut.
Selegilineb
88
Substrates of MAO-A
Serotonin, Norepinephrine, Dopamine, Tyramine
89
Tissue localization of MAO-A
Brain, gut, liver, placenta, skin
90
Substrates of MAO-B
Dopamine, Phenylethylamine
91
Tissue localization of MAO-B
Brain, platelets, lymphocytes